Icon Advisers Has Increased Royal Caribbean Cruises LTD (RCL) Holding By $2.87 Million; Baker Bros Advisors LP Has Lowered Foamix Pharmaceuticals LTD (FOMX) Stake

June 17, 2018 - By Kurt Siggers

Royal Caribbean Cruises Ltd. (NYSE:RCL) Logo

Baker Bros Advisors Lp decreased Foamix Pharmaceuticals Ltd. (FOMX) stake by 35.18% reported in 2018Q1 SEC filing. Baker Bros Advisors Lp sold 867,711 shares as Foamix Pharmaceuticals Ltd. (FOMX)’s stock declined 13.94%. The Baker Bros Advisors Lp holds 1.60M shares with $8.20 million value, down from 2.47 million last quarter. Foamix Pharmaceuticals Ltd. now has $215.08M valuation. The stock decreased 2.03% or $0.11 during the last trading session, reaching $5.31. About 66,411 shares traded. Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) has risen 26.35% since June 17, 2017 and is uptrending. It has outperformed by 13.78% the S&P500. Some Historical FOMX News: ; 15/05/2018 – Orbimed Advisors Buys New 2.7% Position in Foamix; 08/05/2018 – Foamix Pharmaceuticals 1Q Loss $26M; 07/05/2018 – Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101; 08/05/2018 – Foamix Pharmaceuticals 1Q Loss/Shr 69c; 24/04/2018 Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for May 9; 14/05/2018 – Senzar Asset Management LLC Exits Position in Foamix

Icon Advisers Inc increased Royal Caribbean Cruises Ltd. (RCL) stake by 26.44% reported in 2018Q1 SEC filing. Icon Advisers Inc acquired 24,552 shares as Royal Caribbean Cruises Ltd. (RCL)’s stock declined 15.80%. The Icon Advisers Inc holds 117,422 shares with $13.83M value, up from 92,870 last quarter. Royal Caribbean Cruises Ltd. now has $24.25B valuation. The stock increased 0.89% or $1.01 during the last trading session, reaching $114.51. About 3.38M shares traded or 79.19% up from the average. Royal Caribbean Cruises Ltd. (NYSE:RCL) has declined 0.42% since June 17, 2017 and is downtrending. It has underperformed by 12.99% the S&P500. Some Historical RCL News: ; 26/04/2018 – ROYAL CARIBBEAN CRUISES LTD – QTRLY TOTAL REVENUE $2.03 BLN VS $2.01 BLN REPORTED LAST YEAR; 15/03/2018 – Royal Caribbean, Carnival Named Most Instagrammed Cruise Lines According to Seahub.com; 20/04/2018 – Royal Caribbean To Hold Conference Call On First Quarter 2018 Earnings; 26/04/2018 – Royal Caribbean 1Q Rev $2.03B; 15/03/2018 – Royal Caribbean Eyes Next Generation of Cruisers with Multibillion-Dollar Investment In Ships, Experiences and Destinations; 09/05/2018 – ROYAL CARIBBEAN CRUISES DECLARES DIV,: $1B SHR REPURCHASE; 23/04/2018 – DJ Royal Caribbean Cruises Ltd, Inst Holders, 1Q 2018 (RCL); 26/04/2018 – ROYAL CARIBBEAN CRUISES LTD RCL.N FY2018 SHR VIEW $8.76 — THOMSON REUTERS l/B/E/S; 26/04/2018 – ROYAL CARIBBEAN CRUISES LTD QTRLY ADJUSTED EARNINGS OF $1.09 PER SHARE; 29/03/2018 – Cruise Critic: Royal Caribbean Looking at More Affordable Version of the Ultimate Family Suite for Other Ships

Analysts await Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) to report earnings on August, 14. They expect $-0.59 earnings per share, down 34.09% or $0.15 from last year’s $-0.44 per share. After $-0.69 actual earnings per share reported by Foamix Pharmaceuticals Ltd. for the previous quarter, Wall Street now forecasts -14.49% EPS growth.

Baker Bros Advisors Lp increased Ascendis Pharma A/S stake by 218,534 shares to 2.84 million valued at $185.56M in 2018Q1. It also upped Invitae Corporation stake by 1.11 million shares and now owns 8.40M shares. Avexis Inc. was raised too.

Another recent and important Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) news was published by Globenewswire.com which published an article titled: “Foamix Pharmaceuticals to Participate in the Cantor Dermatology & Aesthetics Summit” on June 14, 2018.

Among 3 analysts covering Foamix Pharmaceuticals (NASDAQ:FOMX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Foamix Pharmaceuticals had 8 analyst reports since August 25, 2015 according to SRatingsIntel. Zacks downgraded Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) on Tuesday, August 25 to “Hold” rating. The rating was initiated by Guggenheim on Tuesday, December 5 with “Buy”. H.C. Wainwright maintained it with “Buy” rating and $1200 target in Tuesday, May 8 report. The stock of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) earned “Buy” rating by H.C. Wainwright on Tuesday, April 17. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, November 29. The firm earned “Buy” rating on Friday, January 5 by H.C. Wainwright.

Investors sentiment decreased to 1.14 in Q1 2018. Its down 0.18, from 1.32 in 2017Q4. It fall, as 49 investors sold RCL shares while 178 reduced holdings. 70 funds opened positions while 189 raised stakes. 144.48 million shares or 6.03% less from 153.74 million shares in 2017Q4 were reported. Robeco Institutional Asset Bv invested in 0.11% or 192,663 shares. Teacher Retirement Of Texas has 87,125 shares. Maverick Capital Limited invested in 70,840 shares or 0.11% of the stock. Liberty Mutual Group Asset Mgmt has 0.02% invested in Royal Caribbean Cruises Ltd. (NYSE:RCL) for 6,858 shares. Lombard Odier Asset (Europe) stated it has 0.02% in Royal Caribbean Cruises Ltd. (NYSE:RCL). South Dakota Council holds 0.07% or 24,501 shares. Ameriprise Fincl invested in 0.2% or 3.83M shares. Scout Invests has 0.82% invested in Royal Caribbean Cruises Ltd. (NYSE:RCL). Bokf Na accumulated 0.08% or 25,115 shares. Thrivent Financial For Lutherans holds 0% or 7,147 shares. The United Kingdom-based Barclays Public Limited Co has invested 0.03% in Royal Caribbean Cruises Ltd. (NYSE:RCL). Pggm Invs holds 0.14% or 216,000 shares in its portfolio. Mitchell Mgmt has 28,444 shares. Virginia Retirement Et Al has 172,300 shares for 0.24% of their portfolio. Central National Bank & Trust Com holds 0.1% or 3,280 shares.

Icon Advisers Inc decreased Eastman Chemical Co. (NYSE:EMN) stake by 13,500 shares to 34,100 valued at $3.60 million in 2018Q1. It also reduced Src Energy Inc stake by 272,200 shares and now owns 2.67M shares. Celgene Corp. (NASDAQ:CELG) was reduced too.

Since January 16, 2018, it had 0 insider buys, and 10 sales for $19.18 million activity. 5,892 shares valued at $772,942 were sold by Liberty Jason T on Thursday, January 25. 20,000 Royal Caribbean Cruises Ltd. (NYSE:RCL) shares with value of $2.53 million were sold by Fain Richard D. 7,404 Royal Caribbean Cruises Ltd. (NYSE:RCL) shares with value of $996,208 were sold by Lutoff-Perlo Lisa. Bayley Michael W also sold $2.50 million worth of Royal Caribbean Cruises Ltd. (NYSE:RCL) shares.

More important recent Royal Caribbean Cruises Ltd. (NYSE:RCL) news were published by: Seekingalpha.com which released: “Attractive valuation on Royal Caribbean highlighted” on June 11, 2018, also Seekingalpha.com published article titled: “Cruise line stocks lower after Morgan Stanley warning”, Themiddlemarket.com published: “M&A daily wrap: TA Associates, ERP, Royal Caribbean, Silversea Cruises, Thoma Bravo, Macy’s, b8ta” on June 14, 2018. More interesting news about Royal Caribbean Cruises Ltd. (NYSE:RCL) was released by: Globenewswire.com and their article: “Report: Developing Opportunities within 58, Yamana Gold, The JM Smucker, Splunk, Royal Caribbean Cruises, and …” with publication date: June 13, 2018.

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Ratings Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>